These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 29725245)

  • 21. [Left ventricular hypertrophy in patients with chronic renal failure treated by hemodialysis].
    Wanic-Kossowska M; Lehmann P; Czekalski S
    Pol Arch Med Wewn; 2002 Jun; 107(6):539-46. PubMed ID: 12375575
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vascular calcification in Mexican hemodialysis patients.
    Rojas-Campos E; Herrera-Llamas R; Montañez-Fernández JL; Martínez-Martínez P; Andrade-Sierra J; Avila-Baray AA; Cueto-Manzano AM
    Arch Med Res; 2013 Nov; 44(8):628-32. PubMed ID: 24211752
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hypoalbuminemia as a risk factor for progressive left-ventricular hypertrophy in hemodialysis patients.
    Moon KH; Song IS; Yang WS; Shin YT; Kim SB; Song JK; Park JS
    Am J Nephrol; 2000; 20(5):396-401. PubMed ID: 11092998
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cross-sectional association of volume, blood pressures, and aortic stiffness with left ventricular mass in incident hemodialysis patients: the Predictors of Arrhythmic and Cardiovascular Risk in End-Stage Renal Disease (PACE) study.
    Kim ED; Sozio SM; Estrella MM; Jaar BG; Shafi T; Meoni LA; Kao WH; Lima JA; Parekh RS
    BMC Nephrol; 2015 Aug; 16():131. PubMed ID: 26249016
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Blood pressures values during evaluation of 24-h ambulatory blood pressure monitoring and left ventricular hypertrophy in patients with chronic renal failure treated with hemodialysis (HD)].
    Wanic-Kossowska M; Leman P; Kobelski M; Czekalski S
    Pol Arch Med Wewn; 2002 Jan; 107(1):29-35. PubMed ID: 12046341
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A novel association between residual renal function and left ventricular hypertrophy in peritoneal dialysis patients.
    Wang AY; Wang M; Woo J; Law MC; Chow KM; Li PK; Lui SF; Sanderson JE
    Kidney Int; 2002 Aug; 62(2):639-47. PubMed ID: 12110029
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Abdominal aortic calcification is not superior over other vascular calcification in predicting mortality in hemodialysis patients: a retrospective observational study.
    Hong D; Wu S; Pu L; Wang F; Wang J; Wang Z; Gao H; Zhang Y; Deng F; Li G; He Q; Wang L
    BMC Nephrol; 2013 Jun; 14():120. PubMed ID: 23738982
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative assessment of 2-dimensional echocardiography vs cardiac magnetic resonance imaging in measuring left ventricular mass in patients with and without end-stage renal disease.
    Jakubovic BD; Wald R; Goldstein MB; Leong-Poi H; Yuen DA; Perl J; Lima JA; Liu JJ; Kirpalani A; Dacouris N; Wald R; Connelly KA; Yan AT
    Can J Cardiol; 2013 Mar; 29(3):384-90. PubMed ID: 23103220
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Exploring the relation between mortality and left ventricular structure and function in stable hemodialysis treated patients, a longitudinal multicenter cohort study.
    Chisavu LA; Apostol A; Pop GN; Ivan V; Schiller O; Bob F; Marc L; Mihaescu A; Gadalean F; Grosu I; Timar B; Schiller A
    Sci Rep; 2021 Jun; 11(1):12694. PubMed ID: 34135351
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association between vascular calcification assessed by simple radiography and non-fatal cardiovascular events in hemodialysis patients.
    Petrauskiene V; Vaiciuniene R; Bumblyte IA; Kuzminskis V; Ziginskiene E; Grazulis S; Jonaitiene E
    Nephrol Ther; 2016 Dec; 12(7):503-507. PubMed ID: 27776971
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Left ventricular hypertrophy in pediatric patients on maintenance dialysis: a report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS).
    Merrill K; Galbiati S; Mitsnefes M;
    Pediatr Nephrol; 2023 Jun; 38(6):1925-1933. PubMed ID: 36357637
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Left Ventricular Hypertrophy Predicts Cardiovascular Events in Hypertensive Patients With Coronary Artery Calcifications.
    Grossman C; Levin M; Koren-Morag N; Bornstein G; Leibowitz A; Ben-Zvi I; Shemesh J; Grossman E
    Am J Hypertens; 2018 Feb; 31(3):313-320. PubMed ID: 29036433
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Left ventricular hypertrophy in chronic hemodialysis patients at CNHU-HKM of Cotonou].
    Vigan J; Ahoui S; Hounsou D; Goudoté ACK; Vehounkpe Sacca J
    Nephrol Ther; 2018 Feb; 14(1):29-34. PubMed ID: 29276083
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Left ventricular hypertrophy in incident dialysis patients randomized to treatment with hemofiltration or hemodialysis: results from the ProFil study.
    Alvestrand A; Ledebo I; Hagerman I; Wingren K; Mattsson E; Qureshi AR; Gutierrez A
    Blood Purif; 2011; 32(1):21-9. PubMed ID: 21252503
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vascular calcification is not related to serum fetuin-A and osteopontin levels in hemodialysis patients.
    Ulutas O; Taskapan MC; Dogan A; Baysal T; Taskapan H
    Int Urol Nephrol; 2018 Jan; 50(1):137-142. PubMed ID: 29134617
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of short daily hemodialysis and extended standard hemodialysis on blood pressure and cardiac hypertrophy: a comparative study.
    Fagugli RM; Pasini P; Pasticci F; Ciao G; Cicconi B; Buoncristiani U
    J Nephrol; 2006; 19(1):77-83. PubMed ID: 16523430
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical impact of coexisting retinopathy and vascular calcification on chronic kidney disease progression and cardiovascular events.
    Hwang HS; Kim SY; Hong YA; Cho WK; Chang YK; Shin SJ; Yang CW; Kim SY; Yoon HE
    Nutr Metab Cardiovasc Dis; 2016 Jul; 26(7):590-596. PubMed ID: 27089976
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The combined prognostic significance of alkaline phosphatase and vascular calcification in patients with end-stage kidney disease.
    Kim DW; Hwang SY; Nam YJ; Kim D; Shin SJ; Yoon HE
    Nutr Metab Cardiovasc Dis; 2020 Aug; 30(9):1476-1483. PubMed ID: 32586735
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association between hippuric acid and left ventricular hypertrophy in maintenance hemodialysis patients.
    Yu TH; Tang WH; Lu YC; Wang CP; Hung WC; Wu CC; Tsai IT; Chung FM; Houng JY; Lan WC; Lee YJ
    Clin Chim Acta; 2018 Sep; 484():47-51. PubMed ID: 29758204
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anemia and left ventricular hypertrophy with renal function decline and cardiovascular events in chronic kidney disease.
    Chang JM; Chen SC; Huang JC; Su HM; Chen HC
    Am J Med Sci; 2014 Mar; 347(3):183-9. PubMed ID: 23426086
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.